Clinical Trial Update: IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for IN10018 in combination with RNK08954 for KRASG12D mutation-positive locally advanced or metastatic solid tumors; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma
• Solid Tumors

Drugs mentioned

• IN10018
• RNK08954

Snippet

Sponsor: InxMed (Shanghai) Co., Ltd. | Conditions: Solid Tumor Cancer, PDAC | Phase 1, Phase 2 | Status: RECRUITING